Objective: Most studies based on state and nationwide registries evaluating perioperative outcome after carotid endarterectomy (CEA) rely on hospital discharge data only. Therefore, the true 30-day complication risk after carotid revascularization may be underestimated. Methods: We used the National Surgical Quality Improvement Program database 2005-2010 to assess the in-hospital and postdischarge rate of any stroke, death, cardiac event (new Q-wave myocardial infarction or cardiac arrest), and combined stroke/death and combined adverse outcome (S/D/CE) at 30 days following CEA. Multivariable analyses were used to identify predictors for in-hospital and postdischarge events separately, and in particular, those that predict postdischarge events distinctly. Results: A total of 35,916 patients who underwent CEA during 2005-2010 were identified in the National Surgical Quality Improvement Program database; 59% were male, median age was 72 years, and 44% had a previous neurologic event. Thirty-day stroke rate was 1.6% (n [ 591), death rate was 0.8% (n [ 272), cardiac event rate was 1.0% (n [ 350), stroke or death rate was 2.2% (n [ 794), and combined S/D/CE rate was 2.9% (n [ 1043); 33% of strokes, 53% of deaths, 32% of cardiac events, 40% of combined stroke/death, and 38% of combined S/D/CE took place after hospital discharge. Patients with a prior stroke or transient ischemic attack had similar proportions of postdischarge events compared with patients without prior symptoms. Independent predictors for postdischarge events, but not for inhospital events were female sex (stroke [odds ratio (OR), 1.6; 95% confidence interval (CI), 1. Conclusions: With 38% of perioperative adverse events after CEA happening posthospitalization, regardless of symptoms status, we need to be alert to the ongoing risks after discharge particularly in women, patients with renal failure, or chronic obstructive pulmonary disease. This emphasizes the need for reporting and comparing 30-day adverse event rates when evaluating outcomes for CEA, or comparing carotid stenting to CEA. (J Vasc Surg 2013;57:1568-75.) 
The benefit of carotid endarterectomy (CEA) and carotid angioplasty and stenting (CAS) is highly influenced by the rate of perioperative adverse events, defined as stroke, myocardial infarction (MI), or mortality up to 30 days after the procedure. Many studies reporting and comparing perioperative complication rates following carotid revascularization rely on state and nation-wide registries, which only include in-hospital data. [1] [2] [3] However, procedure-related complications and mortality after revascularization procedures might also take place after hospital discharge. Results from the Society for Vascular Surgery Vascular Registry suggest that in-hospital events do not reflect the full procedural event rate after CAS and CEA, as an additional 31% and 22% of combined adverse events, respectively, occurred after discharge from the hospital. 4 However, in that analysis, less than 50% of the total patients completed 30-day follow-up, and thus, these estimates may under-or overestimate the true event rates. Others have suggested that 10% to 37% of strokes took place after discharge, but these studies are limited by small study size or incomplete follow-up. 5, 6 Also, these analyses did not include adverse outcomes after CEA other than stroke. To compare and evaluate outcomes of CEA and CAS, it seems crucial to report 30-day outcome. For patients, it is important to understand the true operative risk they are facing when deciding whether to undergo CEA. Those patients who are at high risk to develop procedural-related events after discharge might benefit from closer surveillance after discharge and possibly changes in management. Different preoperative patient characteristics may be related to the timing of events. Our objective was to assess the in-hospital and postdischarge rate of adverse events following CEA in a 100% follow-up cohort at 30 days and to identify independent predictors for the timing of these events.
METHODS
Database. Data were obtained from medical records of patients undergoing CEA between 2005 and 2010 in the American College of Surgeon's National Surgical Quality Improvement Program (NSQIP) database. The NSQIP is a multicenter, prospective quality-improvement registry that includes academic and private US hospitals. In 2005, 37 institutions participated in the program, and the number has increased to 258 by 2010. Demographics, preoperative risk factors, intraoperative variables, and 30-day postoperative mortality and morbidity outcomes are collected, validated, and submitted by a trained and audited surgical clinical nurse-reviewer designated by the American College of Surgeon. No specific procedural information on CEA (such as reconstruction technique, shunt use, type of artery closure, or neurologic monitoring) is captured by the current iteration of NSQIP. Postsurgical data are obtained for the entire 30-day time period, regardless of whether the patient is discharged to the outpatient setting before this time. A detailed description of the NSQIP study methods has been previously published and validated. 7 The NSQIP data are subject to annual auditing, and the reliability of accurate data acquisition has improved with each year. 8 Patient selection. The NSQIP database was queried to identify patients undergoing CEA between 2005 and 2010 using the Current Procedural Terminology codes 35301 and 35390. Cases were selected in which CEA was the primary procedure. Patients undergoing concurrent cardiac surgery were excluded. The remaining procedure data were searched to ensure that no other major procedure was included. Indication for surgery (symptom status and degree of stenosis) is not available in the database. Therefore, we were not able to formally stratify patients by symptom status. However, NSQIP captures a history of a previous neurologic event (stroke, transient ischemic attack [TIA] ) and hemiplegia, without the timing and laterality of these events. This variable was used to distinguish patients who were clearly asymptomatic (ASX) from those who had previous neurologic symptoms (SXS). Recent work from our group showed that those with prior SXS were most likely to be symptomatic. 9 Endpoints and measurements. Our primary endpoint was the development of stroke, death, or a cardiac event within 30 days after CEA. Stroke was defined as the development of an embolic, thrombotic, or hemorrhagic vascular accident or stroke with motor, sensory, or cognitive dysfunction (eg, hemiplegia, hemiparesis, aphasia, sensory deficit, impaired memory) that persists for 24 or more hours. A cardiac event was defined as a new Q-wave MI on electrocardiogram or cardiac arrest that necessitated cardiopulmonary resuscitation. Our secondary endpoint was wound infection, defined as either involving the carotid artery, deep (involving deep soft tissue's eg, fascia and muscle layers of the incision) or a superficial surgical site infection (limited to skin and subcutaneous).
Results were stratified for the in-hospital period (intraoperative or predischarge) and the postdischarge period through 30-days after surgery. Timing to adverse event was recorded per day, starting from the day of surgery (day 0). The proportion of postdischarge events was analyzed for both patients with a history of neurologic symptoms and patients without a history of neurologic symptoms. For in-hospital analysis, patients with postdischarge events were excluded. Likewise, for postdischarge events, patients with in-hospital events were excluded. If patients suffered both in-hospital and postdischarge events, the in-hospital event was counted for analysis. Predictor variables for the primary outcome included demographics and preoperative variables. Continuous variables were categorized for the purpose of this study. Detailed definitions of these variables are listed in the Appendix (online only).
Statistical analysis. Bivariate analysis was carried out to assess the relation of the preoperative variables with the primary outcome (stroke, death, cardiac event or a composite of stroke/death and S/D/CE) at the different time points (in-hospital, postdischarge, 30-day) using Pearson c 2 test and Fisher exact test. Initial bivariate analysis included 29 preoperative demographic and comorbidity variables. Multivariable logistic regression was used to assess independent risk factors for outcome events at each of the above specified time points. Demographics and preoperative variables were entered into the multivariable regression analysis if P < .2 in bivariate analysis. Associations were calculated using backward elimination procedure, in which all variables were entered in the first step and removed stepwise based on the highest nonsignificant P value (P $ .05). After carrying out this iterative process, covariates were included in the final model if predictive of primary outcome events in any of the three specified clinical time intervals with this model demonstrating the contribution of each covariate to timing of events. Odds ratios (ORs) with 95% confidence intervals (CIs) were reported. Hosmer and Lemeshow test was used to test the goodness of fit in each model. Statistical analysis was performed using SPSS v. 19 Timing of events. In-hospital S/D/CE occurred in 656 patients (1.8%). After discharge, an additional 38% of S/D/CE (n ¼ 399; 1.1%) occurred; 33% of strokes (n ¼ 195; 0.5%), 53% of deaths (n ¼ 144; 0.4%), 32% of cardiac events (n ¼ 122; 0.3%), and 40% of stroke/ death (n ¼ 320; 0.9%) occurred after discharge. The proportion of combined S/D/CE after discharge was similar in patients with prior neurologic symptoms vs those without (39% and 38%, respectively). Postdischarge, stroke happened in 34% of patients with prior neurologic symptoms, and in 32% of ASX patients; 52% of deaths, 31% of cardiac events, and 40% of stroke/death occurred after discharge in patients with prior neurologic symptoms, vs 55% of deaths, 33% of cardiac events, and 40% of stroke/death in ASX patients (Table II) . In-hospital adverse events happened at a median of 1 day (IQR, 1). These patients were discharged from the hospital at a median of 7 days (IQR, 8) postoperatively. Patients who experienced postdischarge events were discharged at day 1 (median) postoperatively (IQR, 1). Postdischarge stroke occurred at a median of 8 days after the operation (IQR, 11) (Fig) . MI or cardiac arrest (cardiac events) after discharge took place at a median of 6 days (IQR, 17) and 11 days (IQR, 19), respectively. Patients who survived to discharge but did not survive the postdischarge period, died at a median interval of 11 days (IQR, 15).
Thirty-day wound infection rate was 0.5% (n ¼ 197). The majority of wound infections took place after discharge: 94% of superficial wound infection (n ¼ 141; 0.4%), 94% of deep wound infection (n ¼ 47; 0.1%) and 89% of carotid infection (n ¼ 9; 0.03%).
Predictors for stroke
In-hospital. Independent predictors for in-hospital stroke were redo CEA, a history of stroke/hemiplegia, history of TIA, history of angina/MI, underweight (vs normal weight) and obesity class II (vs normal weight), functional dependent status (vs independent), emergency procedures, and ASA class >3 (Table III) .
Postdischarge. History of stoke/hemiplegia, history of TIA, renal failure, and female sex were associated with increased risk of postdischarge stroke on multivariable analyses (Table III) . Women were more likely to have a postdischarge stroke than men (38.1% vs 29.0%; OR, 1.57; 95% CI, 1.18-2.09; P ¼ .002). In patients with a previous neurologic event, a significantly higher stroke rate was seen in women compared with men (1.0% vs 0.7%; OR, 1.5; 95% CI, 1.1-2.1; P ¼ .02). In ASX patients, the stroke rate was again higher in women with a similar OR, however, this did not reach statistical significance (0.4% vs 0.3%; OR, 1.6; 95% CI, 0.97-2.5; P ¼ .08). Stroke in woman took place at a median of 2 days (IQR, 6), compared with 1 day (IQR, 6) in men (P ¼ .4). Stroke in patients with renal failure took place at a median of 7 days (IQR, 9) after discharge, compared with 1 day (IQR, 6) in patients without renal failure (P < .001). Female gender and renal failure were both predictive for postdischarge stroke in multivariable analysis, but not for in-hospital stroke (Table III) .
Predictors for stroke or death
In-hospital. In multivariable analysis, age >80 years, history of stroke/hemiplegia, history of TIA, history of angina/MI, renal failure, history of revascularization for peripheral vascular disease (PVD), dependent functional status, emergency procedures, and ASA class >3 were independent predictors for stroke or death (Table IV) .
Postdischarge. Female sex, history of stroke/hemiplegia, history of angina/MI, renal failure, chronic obstructive pulmonary disease (COPD) and dependent functional status were independently associated with postdischarge stroke or death. Female sex and COPD were predictive for postdischarge stroke/death, but not for in-hospital events (Table IV) .
Predictors for other adverse events
A history of COPD or dyspnea was predictive for postdischarge and 30-day death but not for in-hospital death. (Table V , online only) For cardiac events, no differential predictors were identified in the postdischarge time period compared with in-hospital time frame (Table VI, online only). As was seen with death and stroke/death, patients with a history of COPD were at increased risk for postdischarge and 30-day combined S/ D/CE but not for in-hospital adverse events (Table VII, online only). Although the risk factors identified for 
DISCUSSION
In a large number of patients among both community and academic institutions in the United States, CEA was performed with very low complication rates for stroke, death, or cardiac events (MI or cardiac arrest). Approximately one-third of procedural-related events occur after discharge from the hospital. This was true for both patients with prior neurologic symptoms and for those who were asymptomatic. In this study, we identified predictors for postdischarge events, which have not previously been reported. We found that independent predictors for postdischarge events but not for in-hospital events were female sex (stroke and stroke/death), renal failure (stroke), and COPD (death, stroke/death, and S/D/CE).
Previously, Sidawy et al 4 described the occurrence of adverse events happening after discharge but within 30 days of revascularization. For CAS, they found that 31% of combined strokes/deaths or MIs were not captured during hospital admission; for CEA, 28% of events were missed when only analyzing in-hospital data. Although less than one-half of patients in that analysis had 30-day follow-up, our results confirm these estimates in a 100% follow-up cohort. Most administrative vascular registries do not include postdischarge events. The results of this study indicate that this may be a confounding feature for many studies based on such datasets. [1] [2] [3] 10 It is well known that hospital administrative data are not reliable to estimate nonfatal operative complication rates for surgical procedures in general. 11 Recently, the reliability of administrative data to determine outcomes specifically for carotid revascularization procedures was questioned. 9, 12 Consistent entry of data beyond the in-hospital period seems to be not only important for true perioperative event risk estimation but also to identify patients at risk for adverse perioperative events. Registries such as the NSQIP are critical to evaluate rare events such as postoperative stroke after CEA since single-surgeon or single-center experiences are typically underpowered to evaluate procedures with low event rates. Our results demonstrate that in a subgroup of patients, adverse events are more likely to happen after discharge, possibly influencing preoperative counseling and perioperative management. The timing of strokes suggests that some may be due to hyperperfusion and subsequent intracerebral hemorrhage. 13, 14 Intracerebral hemorrhage occurs at unpredictable intervals in the postoperative course and its mechanism remains unclear. Previous analyses identified high-grade stenosis and severe intra-or postoperative hypertension as possible risk factors. 13 Better blood pressure control and perhaps selective transcranial Doppler monitoring might benefit these patients. 15 "Late" stroke might also occur due to thromboembolism 13 in patients who do not respond to antiplatelet therapy. Preoperative testing for antiplatelet responsiveness may identify subgroups at risk that may benefit from additional antiplatelet medication. Unfortunately, the type and laterality of postoperative stroke is not captured in the NSQIP. Future research efforts should evaluate the mechanism of postoperative stroke to guide further changes in perioperative management. 
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In our study, we found that stroke in women seems to happen more frequently after discharge. Studies based on in-hospital results did not find differences in stroke and death rates after CAS and CEA in relation to sex. 10, 16 However, several others have also identified women as a subgroup of patients at higher risk for 30-day adverse outcome after CEA. 6, 17 Especially for asymptomatic women, the benefit of surgery may be less than that for men. 18, 19 In our analyses, the difference between men and woman in postdischarge events was identified for both those with, and without a previous neurologic event, although this did not quite reach statistical significance for asymptomatic patients. Sex differences in outcome of CEA are still not well understood and merit further investigation. 20, 21 Renal failure was also an independent predictor for postdischarge stroke but not for in-hospital or 30-day stroke. Two studies based on NSQIP data 6, 22 found that impaired renal function was an independent risk factor for mortality and cardiac and pulmonary morbidity after CEA, but was not associated with increased risk of neurologic complications at 30 days, which was consistent with our results. Also, other reports have suggested that renal failure is a risk factor for increased stroke risk and a marker for advanced atherosclerotic disease causing morbidity and mortality. [23] [24] [25] Several authors have reported risk factors associated with adverse outcome after CEA to identify high-risk groups and optimize management of patients with carotid artery disease. 5, 6, 18, 26, 27 Similar to prior reports, we found that symptom status was a consistent predictor for adverse events (both in-hospital and postdischarge), and that a history of preoperative stroke was more predictive than a history of TIA. 27, 28 Among other risk factors for only in-hospital or both in-hospital and postdischarge outcome, we identified several patient characteristics previously described by others, including diabetes 26, 27 and age >80 years. 27 ,29 Interestingly, we found that patients with redo CEA had increased risk for in-hospital stroke, whereas others did not 30, 31 or only identified increased risk for local complications such as cranial nerve injury. 32 However, these studies might not have detected a difference because of low event rates and small sample sizes. Adequately powered studies are needed to define optimal treatment in these patients. Under-and overweight patients had an increased risk for stroke, suggesting that obesity is not only a risk factor for mortality 33, 34 but also for morbidity after CEA. This obesity paradox has been previously identified with vascular surgery procedures with a reverse J-shaped relation of BMI and adverse outcome, with the highest risk in the underweight and morbidly obese extremes, and the lowest rates in the overweight and mildly obese patients. [33] [34] [35] [36] Not surprisingly and consistent with previous literature, 5,27,37 emergent procedures were predictive for all in-hospital adverse outcomes. This increased risk was, however, not persistent after discharge. This is understandable, as most emergent procedures would be presumed to be performed for either stroke-in-evolution or crescendo TIA. 28, 38 This study has several limitations. NSQIP does not define preoperative symptom status in the same manner as most clinical trials. 6 Although a recent report from our group showed that NSQIP does identify symptomatic patients with a high sensitivity, the number of falsepositives was about 25% (because of stroke or TIA occurring >6 months prior to surgery or contralateral to the CEA).
9 Therefore, we were only able to stratify the analysis regarding timing of events for patients with and without a previous neurologic event and accounted for these symptoms individually in multivariable prediction models. However, importantly, we did not find a difference in the occurrence of postdischarge stroke in those who were clearly asymptomatic compared with a group who had preoperative neurologic events, the vast majority of which were likely within 6 months of and ipsilateral to their CEA. Another limitation inherent to this database is the lack of anatomical preoperative factors such as history of previous neck radiation, degree of stenosis, or radical neck dissection. Also, the retrospective nature of the data may introduce a selection bias, which might have influenced the results. Because nonfatal cardiac events proved to have a strong effect on patient survival, we included cardiac events as one of our primary outcome measures. Our definition of a cardiac event will capture both cardiac arrest and new Q-wave MI on electrocardiogram but is somewhat limited by the NSQIP database because patients with ST-elevation MI (troponin leak) will be missed. Lastly, CAS procedures are not yet included in the NSQIP but will be in the future allowing comparison of the two procedures.
CONCLUSIONS
With 38% of perioperative adverse events after CEA happening posthospitalization, regardless of symptom status, surgeons should be alert to the ongoing risks after discharge particularly in women and patients with renal failure or a history of COPD. For research and quality improvement purposes, the full 30-day adverse event rates should be reported and compared when evaluating CEA or comparing CAS and CEA. 
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